Wegovy and Ozempic ingredient linked to rare stomach paralysis cases

A study involving 16 million people in the US found that those prescribed so-called GLP-1-agonists had an increased risk of serious gastrointestinal conditions, including stomach paralysis

Related Keywords

Denmark ,New York ,United States ,United Kingdom ,Canada ,Danish ,British ,Mohit Sodhi ,Health Check ,Novo Nordisk ,Drug Administration ,University Of British Columbia ,British Columbia ,Reshmi Srinath ,Mount Sinai Hospital ,Obesity ,Health ,Weight Loss ,